Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $1.46 Million - $1.66 Million
6,200 Added 62.0%
16,200 $4.05 Million
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $2.25 Million - $2.56 Million
-10,000 Reduced 50.0%
10,000 $2.5 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $1.54 Million - $1.93 Million
-8,300 Reduced 29.33%
20,000 $4.63 Million
Q3 2023

Nov 14, 2023

SELL
$233.08 - $265.59 $396,236 - $451,502
-1,700 Reduced 5.67%
28,300 $7.02 Million
Q2 2023

Aug 14, 2023

SELL
$224.99 - $256.14 $449,980 - $512,280
-2,000 Reduced 6.25%
30,000 $7.2 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $5.27 Million - $6.09 Million
22,000 Added 220.0%
32,000 $8.07 Million
Q1 2022

May 16, 2022

SELL
$257.27 - $315.76 $15.4 Million - $18.9 Million
-60,000 Reduced 85.71%
10,000 $2.93 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $1.4 Million - $1.58 Million
4,800 Added 7.36%
70,000 $23 Million
Q3 2021

Nov 15, 2021

BUY
$272.21 - $332.43 $4.14 Million - $5.05 Million
15,200 Added 30.4%
65,200 $19.8 Million
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $3.7 Million - $4.27 Million
17,400 Added 53.37%
50,000 $11.1 Million
Q3 2020

Nov 16, 2020

BUY
$177.16 - $215.33 $460,616 - $559,858
2,600 Added 8.67%
32,600 $7.02 Million
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $509,838 - $710,010
-4,200 Reduced 12.28%
30,000 $4.15 Million
Q4 2019

Feb 14, 2020

BUY
$133.47 - $153.48 $226,899 - $260,915
1,700 Added 5.23%
34,200 $5.25 Million
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $1.06 Million - $1.14 Million
7,800 Added 31.58%
32,500 $4.69 Million
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $3.08 Million - $3.55 Million
24,700 New
24,700 $3.53 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $180B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.